|
P001
|
Microbiological trends and outcomes in infective endocarditis: a nationwide cohort study
Poster flashes
SSI – Swiss Society for Infectious Diseases
H. Buergler Cantonal Hospital Aarau, Aarau, SwitzerlandC. Gregoriano Cantonal Hospital Aarau, Aarau, SwitzerlandR. Laager Cantonal Hospital Aarau, Aarau, SwitzerlandP. Schuetz Cantonal Hospital Aarau, Aarau, SwitzerlandA. Conen
Speaker
Cantonal Hospital Aarau, Aarau, SwitzerlandA. Kutz Cantonal Hospital Aarau, Aarau, Switzerland; Brigham and Women's Hospital and Harvard Medical School Boston, Massachusetts, US
|
|
P002
|
Emergence of toxigenic Corynebacterium diphtheriae infections in elderly patients in Switzerland - report of an ongoing outbreak investigation
Poster flashes
SSI – Swiss Society for Infectious Diseases
P. Urwyler
Speaker
Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, SwitzerlandD. Goldenberger Clinical Bacteriology/Mycology, University Hospital Basel, Basel, SwitzerlandK. Grosheintz Department of Health, Canton of Basel-Stadt, Basel, SwitzerlandR. Tarnutzer Department of Health, Canton of Basel-Stadt, Basel, SwitzerlandM. Markstein Department of Health, Canton of Basel-Stadt, Basel, SwitzerlandC. Sucker Department of Health, Canton of Basel-Stadt, Basel, SwitzerlandA. Balestra Division of Pneumology, St. Claraspital Basel, Basel, SwitzerlandL. Merki Intensive Care Medicine, St. Claraspital Basel, Basel, SwitzerlandM. Baumann Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, SwitzerlandN. Gürtler Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, SwitzerlandA. Martinez Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, SwitzerlandM. von Rotz Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, SwitzerlandP. Schläpfer Clinical Bacteriology/Mycology, University Hospital Basel, Basel, SwitzerlandY. Lim Clinical Bacteriology/Mycology, University Hospital Basel, Basel, SwitzerlandC. Lang Clinical Bacteriology/Mycology, University Hospital Basel, Basel, SwitzerlandB. Ivan Clinical Bacteriology/Mycology, University Hospital Basel, Basel, SwitzerlandP. Keller Clinical Bacteriology/Mycology, University Hospital Basel, Basel, SwitzerlandE. Wuerfel Department of Health, Canton of Basel-Stadt, Basel, SwitzerlandS. Tschudin Sutter Division of Infectious Diseases & Hospital Epidemiology and Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland
|
|
P003
|
Trained immunity drives neutrophil reprogramming providing protection against pneumococcal sepsis
Poster flashes
SSI – Swiss Society for Infectious Diseases
C. Gilbert
Speaker
Lausanne University Hospital and University of LausanneT. Snäkä Lausanne University Hospital and University of LausanneM. Brochut Lausanne University Hospital and University of LausanneC. Théroude Lausanne University Hospital and University of LausanneM. Reverte Lausanne University Hospital and University of LausanneD. Le Roy Lausanne University Hospital and University of LausanneT. Roger Lausanne University Hospital and University of Lausanne
|
|
P004
|
Enhancing care through digitalization: Sepsis quality of care as an example
Poster flashes
SSI – Swiss Society for Infectious Diseases
J. Despraz
Speaker
CHUV - Hôpital universitaireR. Matusiak Swiss Data Science CenterS. Nektarijevic Swiss Data Science CenterF. Bastardot CHUV - Hôpital universitaireR. Akrour CHUV - Hôpital universitaireC. Galland-Decker CHUV - Hôpital universitaireA. Konasch CHUV - Hôpital universitaireO. Pignolet CHUV - Hôpital universitaireS. Pepe CHUV - Hôpital universitaireJ. Chiche CHUV - Hôpital universitaireI. Lehn CHUV - Hôpital universitaireM. Roth-Kleiner CHUV - Hôpital universitaireD. Kaufmann CHUV - Hôpital universitaireT. Calandra CHUV - Hôpital universitaireJ. Raisaro CHUV - Hôpital universitaireS. Meylan CHUV - Hôpital universitaire
|
|
P005
|
Machine Learning-Based Prediction of Active Tuberculosis in people with HIV using Clinical Data
Poster flashes
SSI – Swiss Society for Infectious Diseases
L. Bartl
Speaker
Universitätsspital ZürichM. Zeeb Universität Zürich, Universitätsspital ZürichM. Kälin Universitätsspital ZürichT. Loosli Universität Zürich, Universitätsspital ZürichJ. Notter Kantonsspital Sankt GallenH. Furrer Insel Gruppe AG, Inselspital, Universitätsspital BernM. Hoffmann Kantonspital OltenH. Hirsch Universitätsspital BaselR. Zangerle Medical Universitiy InnsbruckK. Grabmeier-Pfistershammer Medical University of Vienna, Vienna General HospitalM. Knappik Klinik PenzingA. Calmy University Hospital Geneva, SwitzerlandM. Cavassini University Hospital Lausanne, Lausanne, SwitzerlandN. Labhardt Universitätsspital BaselE. Bernasconi Ente Ospedaliero CantonaleH. Günthard Universität Zürich, Universitätsspital ZürichR. Kouyos Universität Zürich, Universitätsspital ZürichK. Kusejko Universität Zürich, Universitätsspital ZürichJ. Nemeth Universitätsspital Zürich
|
|
P006
|
|
|
P007
|
Cohort Profile: The Swiss Mother and Child HIV Cohort Study (MoCHiV)
Poster flashes
SSI – Swiss Society for Infectious Diseases
P. Paioni
Speaker
Universitäts- Kinderspital ZürichM. Capaul University Hospital ZurichA. Brunner Bürgerspital SolothurnA. Traytel University Hospital ZurichK. Aebi-Popp Lindenhofspital Bern, Bern, SwitzerlandP. Crisinel Lausanne University Hospital and University of LausanneA. Duppenthaler Inselspital, Bern University HospitalH. Günthard University Hospital ZurichB. Martinez de Tejada University Hospitals GenevaL. Kottanattu EOC Ospedale Regionale di Bellinzona e ValliS. Marcel University Hospital BaselA. Rauch Inselspital, Bern University HospitalN. Wagner University Hospitals GenevaI. Hoesli University Hospital BaselC. Rudin University Children's Hospital Basel, SwitzerlandA. Scherrer University Hospital ZurichK. Kusejko University Hospital ZurichC. Kahlert Children's Hospital of Eastern Switzerland
|
|
P008
|
Duration of viral shedding in immunocompromised patients with SARS-CoV-2 infection
Poster flashes
SSI – Swiss Society for Infectious Diseases
M. von Rotz
Speaker
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, SwitzerlandP. Urwyler
Speaker
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, SwitzerlandK. Leuzinger Clinical Virology, University Hospital Basel, University of Basel, Basel, SwitzerlandH. Hirsch Transplantation and Clinical Virology, Department Biomedicine, University of Basel, Basel, SwitzerlandS. Jost Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, SwitzerlandE. Golshetti Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, SwitzerlandS. Ragozzino Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, SwitzerlandR. Kuehl Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, SwitzerlandN. Khanna Division of Infectious Diseases and Hospital Epidemiology and Department of Clinical Research, University Hospital Basel, University of Basel, Basel, SwitzerlandS. Tschudin Sutter Division of Infectious Diseases and Hospital Epidemiology and Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland
|
|
P009
|
|
|
P010
|
Concurrent detection of Swine Influenza A Virus (H1N1) in a farmer and pigs in Switzerland: Potential zoonotic event.
Poster flashes
SSI – Swiss Society for Infectious Diseases
M. Mwanga
Speaker
Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandJ. Steiner Clinic for Swine, Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, Bern, SwitzerlandM. Licheri Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandM. Licheri Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandH. Nathues Clinic for Swine, Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, Bern, SwitzerlandR. Dijkman Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandJ. Kelly Institute of Virology and Immunology, Bern and Mittelhäusern
|
|
P011
|
Epidemiological trends and resistance patterns of Citrobacter spp. in Switzerland: a nationwide, retrospective surveillance study
Poster flashes
SSI – Swiss Society for Infectious Diseases
P. FONTON
Speaker
Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. R. GRANT Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. M. GASSER Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of Bern, Bern, Switzerland.A. KRONENBERG Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of Bern, Bern, Switzerland.S. HARBARTH Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
|
|
P012
|
Cross-species transmission and evolution of Coronaviruses at the interface of camelids and humans
Poster flashes
SSI – Swiss Society for Infectious Diseases
S. Ochsenbein
Speaker
Institute of Virology and Immunology (IVI), Bern and MittelhäusernA. Kratzel Institute of Virology and Immunology (IVI), Bern and MittelhäusernV. Flück Institute of Virology and Immunology (IVI), Bern and MittelhäusernM. Gultom Cardiovascular Research Cluster BernB. Trüeb Institute of Virology and Immunology (IVI), Bern and MittelhäusernG. Zimmer Institute of Virology and Immunology (IVI), Bern and MittelhäusernG. Zimmer Institute of Virology and Immunology (IVI), Bern and MittelhäusernM. Müller Institut für Virologie, Charite BerlinJ. Drexler Institut für Virologie, Charite BerlinR. Dijkman Institute for Infectious Diseases, University of Bern, SwitzerlandJ. Kelly Institute of Virology and Immunology (IVI), Bern and MittelhäusernS. Pfänder Leibniz-Institut für VirologieC. Drosten Institut für Virologie, Charite BerlinV. Thiel Institute of Virology and Immunology (IVI), Bern and Mittelhäusern
|
|
P013a
|
Phase 2 Study of Switch to Daily BIC + LEN in Individuals on a Multi-tablet HIV Treatment Regimen
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
K. Mounzer Philadelphia FIGHT Community Health CentersJ. Slim New York Medical CollegeM. Ramgopal Midway Immunology and Research CenterM. Hedgcock Spectrum HealthM. Bloch Holdsworth House Medical PracticeJ. Santana University of Puerto RicoI. Mendes Gilead Sciences, Inc.Y. Guo Gilead Sciences, Inc.P. Arora Gilead Sciences, Inc.J. Montezuma-Rusca Gilead Sciences, Inc.P. Sklar Gilead Sciences, Inc.T. Grabinger
Speaker
Gilead Sciences Switzerland SàrlJ. Baeten Gilead Sciences, Inc.S. Segal-Maurer New York Presbyterian Queens
|
|
P013b
|
Using weight loss to predict outcome and define a humane endpoint in preclinical sepsis studies
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
M. Brochut Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)T. Heinonen Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)T. Snäkä Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)C. Gilbert Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)D. Le Roy Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)T. Roger
Speaker
Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
|
|
P014
|
Beta-lactam antibiotics penetration in bone and soft tissues
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
A. Cancela Costa
Speaker
Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)S. Vingerhoets Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)S. Steinmetz Septic Surgery Service of Lausanne University Hospital (CHUV)A. Kritikos Infectious Diseases Service of Fribourg HospitalE. Glampedakis Vaud Preventive Medicine UnitG. Sauvain Laboratory and Service of Clinical Pharmacology of Lausanne University Hospital (CHUV)J. Pagani Service of Intensive Care Medicine of Lausanne University Hospital (CHUV)L. Decosterd Laboratory and Service of Clinical Pharmacology of Lausanne University Hospital (CHUV)F. Lamoth Infectious Diseases Service and Institute of Microbiology of Lausanne University Hospital (CHUV)
|
|
P015
|
Prospective identification of individuals at high risk of sexually transmitted infections: development of a machine learning based algorithm for screening
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
A. Farnham
Speaker
Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of ZurichJ. Fehr Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of ZurichJ. Notter Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandB. Surial Department of Infectious Diseases, Bern University Hospital and University of Bern, Bern, SwitzerlandV. Christinet Checkpoint VaudD. Braun Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, SwitzerlandR. Kouyos Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, SwitzerlandN. Low Institute of Social and Preventive Medicine, University of Bern, Bern, SwitzerlandB. Hampel Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich and Checkpoint Zurich
|
|
P016
|
Preliminary data of a multicenter retrospective analysis on invasive Group A Streptococcus (iGAS) infection in adults in Switzerland (iGASWISS) during winter 2022-23
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
S. Musumeci
Speaker
HUG - Hôpitaux Universitaires de GenèveM. Weisser Rohacek Basel University HospitalA. Erba Basel University HospitalD. Goldenberger Basel University HospitalC. Lang Basel University HospitalE. Colin-Benoit Bern University Hospital (Inselspital)S. Leib Institute for Infectious Diseases, University of BernP. Sendi Institute for Infectious Diseases, University of BernC. Chuard Fribourg Cantonal HospitalV. Erard Fribourg Cantonal HospitalC. Fournier Fribourg Cantonal HospitalL. Cobuccio CHUV - Lausanne University HospitalF. Tagini CHUV - Lausanne University HospitalC. Bertelli CHUV - Lausanne University HospitalL. Senn CHUV - Lausanne University HospitalR. Sommerstein Faculty of Healthcare Sciences and Medicine, Klinik St. Anna, University of LucerneG. Blättler Faculty of Healthcare Sciences and Medicine, Klinik St. Anna, University of LucerneC. Vieira Gomes Cantonal Hospital of ValaisM. Moraz Cantonal Hospital of ValaisS. Emonet Cantonal Hospital of ValaisC. Strahm Cantonal Hospital of St Gallen, St Gallen, SwitzerlandP. Kohler Cantonal Hospital of St Gallen, St Gallen, SwitzerlandS. Seiffert Cantonal Hospital of St Gallen, St Gallen, SwitzerlandK. Herzog Spital Thurgau AGD. Vuichard Gysin Spital Thurgau AGS. Brugger Zurich University Hospital and University of ZurichO. Nolte Zurich University Hospital and University of ZurichA. Egli Zurich University Hospital and University of ZurichD. Weller Zurich University Hospital and University of ZurichA. Andrianaki Zurich University Hospital and University of ZurichA. Zinkernagel Zurich University Hospital and University of ZurichD. Vu Cantero Direction générale de la santéA. Uribe Caparros Direction générale de la santéP. François HUG - Hôpitaux Universitaires de GenèveJ. Schrenzel HUG - Hôpitaux Universitaires de Genève
|
|
P017
|
Uptake and Discontinuation of the Long-Acting Duo: 24-Month Preliminary Analysis on Cabotegravir Plus Rilpivirine in the Swiss HIV Cohort Study
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
J. Duran Ramirez University Hospital Zurich / University of ZurichK. Kusejko University Hospital Zurich / University of ZurichK. Metzner University Hospital Zurich / University of ZurichM. Huber University of ZurichY. Martin Bern University Hospital and University of BernM. Stöckle University Hospital Basel, University of BaselA. Calmy University Hospital Geneva, University of GenevaL. Decosterd Lausanne University Hospital, University of LausanneM. Cavassini Department of Infectious DiseasesE. Bernasconi University of Geneva and University of Southern SwitzerlandP. Schmid Cantonal Hospital St GallenH. Günthard University Hospital Zurich / University of ZurichD. Braun
Speaker
University Hospital Zurich / University of Zurich
|
|
P018
|
|
|
P019
|
|
|
P020
|
|
|
P021
|
|
|
P022
|
|
|
P023
|
BOrrelia BUrgdorferi Infections IN Children and Adolescents– a seroprevalence study (BOBUINCA)
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
L. Heeb
Speaker
Universitätskinderspital beider BaselN. Fritschi Children’s Hospital of Central Switzerland, LUKS, Lucerne, SwitzerlandA. Marten Universitätskinderspital beider BaselN. Ritz Children’s Hospital of Central Switzerland, LUKS, Lucerne, SwitzerlandT. Welzel Universitätskinderspital beider BaselU. Heininger Universitätskinderspital beider Basel
|
|
P024
|
|
|
P025
|
|
|
P026
|
Myeloid-derived suppressor-like cells as a prognostic marker in critically ill patients: insights from experimental endotoxemia and intensive care patients.
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
I. Schrijver Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)J. Herderschee Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)C. Théroude Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)A. Kritikos Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)G. Leijte Radboud University Medical CenterD. Le Roy Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)M. Brochut Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)J. Chiche Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)M. Perreau Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)G. Pantaleo Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)B. Guery Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)M. Kox Radboud University Medical CenterP. Pickkers Radboud University Medical CenterT. Calandra Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)T. Roger
Speaker
Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
|
|
P027
|
SOLAR 12-Month European Results: Randomized Switch Trial of CAB+RPV LA vs. Oral BIC/FTC/TAF
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
I. De Los Santos Gil Internal Medicine and Infectious Diseases Department, CIBERINFEC, Instituto de Salud Carlos III, Hospital de la Princesa, Madrid, SpainA. Ustianowski Manchester University NHS Foundation Trust, Manchester, UKG. Orofino Unit of Infectious Diseases, “Divisione A”, Amedeo di Savoia Hospital, Torino, ItalyS. Scholten Praxis Hohenstaufenring, Cologne, GermanyP. Messiaen Department of Infectious Diseases and Immunity, Jessa Hospital, Hasselt, Belgium; Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, BelgiumF. Maggiolo UOC Infectious Diseases, ASST Papa Giovanni XXII, Bergamo, ItalyD. Braun Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, SwitzerlandC. Wyen Praxis am Ebertplatz, Cologne, GermanyR. Demeester University Hospital of Charleroi, Lodelinsart, Charleroi, BelgiumC. Jacomet Infectious Disease Unit, CHU Clermont-Ferrand, COREVIH Auvergne Loire, Clermont-Ferrand, FranceE. Cua Hôpital de L’Archet, Nice, FranceA. Calmy HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, SwitzerlandE. Clarke Liverpool University Hospitals NHS Foundation Trust, Royal Liverpool University Hospital, Liverpool, UKM. Sarcletti HIV Unit, Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, AustriaS. Dakhia ViiV Healthcare, Brentford, UKK. Sutton ViiV Healthcare, Durham, NC, USAD. Sutherland-Phillips ViiV Healthcare, Durham, NC, USAC. Latham ViiV Healthcare, Durham, NC, USAA. Berni GSK, Brentford, UKR. Urbaityte GSK, Brentford, UKM. Pascual-Bernaldez ViiV Healthcare, Madrid, SpainB. Ngenzi ViiV Healthcare, Wavre, Belgium; M. Schroeder ViiV Healthcare, Brentford, UKR. Van Solingen-Ristea Janssen Research & Development, Beerse, BelgiumB. Baugh Janssen Research & Development, Raritan, NJ, USAR. D’Amico ViiV Healthcare, Durham, NC, USAJ. van Wyk ViiV Healthcare, Brentford, UKA. Bianchi
Speaker
ViiV Healthcare GmbH, Münchenbuchsee, Switzerland
|
|
P028
|
Point-of-care lung ultrasound for the detection of pulmonary tuberculosis: the TrUST study
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
V. Suttels
Speaker
CHUV - Hôpital universitaireJ. Du Toit University of the WitwatersrandP. Wachinou CNHUPPCA. Hada CNHUPPCG. Makpemikpa CNHUPPCM. Rafiou CNHUPPCO. Goudjanou CNHUPPCC. Bessat CHUV - Hôpital universitaireA. Roux CHUV - Hôpital universitaireE. Garcia CHUV - Hôpital universitaireT. Brahier CHUV - Hôpital universitaireJ. Doenz EPFL Ecole Polytechnique Fédérale de Lausanne, Lausanne, SwitzerlandJ. Vignoud EPFL Ecole Polytechnique Fédérale de Lausanne, Lausanne, SwitzerlandG. Agodokpessi CNHUPPCD. Affolabi Laboratoire Supranational de Référence des Mycobactéries (LRM)M. Hartley Yale School of MedicineN. Boillat-Blanco CHUV - Hôpital universitaire
|
|
P029
|
|
|
P030
|
Evolution of serotype distribution and clinical syndromes of invasive pneumococcal disease before and during Covid-19 pandemic: A retrospective analysis in Switzerland 2012-2022
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
W. Albrich
Speaker
Cantonal Hospital St.Gallen, St.Gallen, SwitzerlandN. Just Cantonal Hospital St.Gallen, St.Gallen, SwitzerlandC. Kahlert Cantonal Hospital St.Gallen, St.Gallen, SwitzerlandF. Baty Cantonal Hospital St.Gallen, St.Gallen, SwitzerlandM. Hilty University of Bern
|
|
P031
|
Performance of 18F-FDG PET/CT scanner in the diagnosis of endocarditis
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
F. Desgranges
Speaker
Lausanne University Hospital and University of LausanneC. Kamani Lausanne University Hospital and University of LausanneD. Rotzinger Lausanne University Hospital and University of LausanneB. Guery Lausanne University Hospital and University of LausanneN. Ianculescu Lausanne University Hospital and University of LausanneD. Auberson Lausanne University Hospital and University of LausanneG. Tzimas Lausanne University Hospital and University of LausanneS. Hugelshofer Lausanne University Hospital and University of LausanneP. Tozzi Lausanne University Hospital and University of LausanneM. Kirsch Lausanne University Hospital and University of LausanneP. Monney Lausanne University Hospital and University of LausanneJ. Prior Lausanne University Hospital and University of LausanneM. Papadimitriou Olivgeris Lausanne University Hospital and University of Lausanne
|
|
P032
|
|
|
P033
|
Burden of schistosomiasis and strongyloidiasis in Sub-Sahara African participants in the Swiss HIV Cohort Study
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
A. Oberli
Speaker
University of Bern, Institute for Infectious Diseases, Bern, SwitzerlandK. Schläpfer University of Bern, Institute for Infectious Diseases, Bern, SwitzerlandX. Vu University of Bern, Institute for Infectious Diseases, Bern, SwitzerlandA. Amstutz Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland C. Schönenberger Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland N. Labhardt Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland B. Nickel Swiss Tropical and Public Health Institute & University of Basel, Basel, SwitzerlandL. Wammes Department of Parasitology, Leiden University Medical Center, Leiden, NetherlandsA. Neumayr Swiss Tropical and Public Health Institute & University of Basel, Basel, SwitzerlandS. Haller Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandM. Kälin Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, SwitzerlandS. Musumeci HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, SwitzerlandE. Bernasconi Division of infectious diseases, Ente Ospedaliero Cantonale, Lugano & University of Geneva and University of Southern SwitzerlandE. Gauthiez Services of Infectious Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, SwitzerlandA. Rauch Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandC. Staehelin Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandA. Eichenberger Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
|
|
P034
|
Only a quarter of antibiotic prescriptions appropriate for nursing home residents with lower respiratory infections. What factors are associated with prescriptions?
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
A. Roux
Speaker
Infectious Diseases Service, Lausanne University Hospital and University of LausanneD. Vu Communicable disease unit, Division of General cantonal physician, Geneva Directorate of Health; Pediatric Infectious Diseases Unit, Department of Woman, Child and Adolescent, University Hospitals of GenevaA. Niquille Center for Primary Care and Public Health (Unisanté), Pharmacy, University of LausanneE. Rubli Truchard Geriatric Medicine and Geriatric Rehabilitation Division, Lausanne University Hospital and University of LausanneT. Bizzozzero Department of Internal Medicine and Geriatrics, Morges HospitalA. Tahar Division of Internal Medicine for the Aged, Department of Rehabilitation and Geriatrics, Geneva University Hospitals; Division of Primary Care Medecine, Departement of primary Care Medecine, Geneva University HospitalsT. Morlan Division of Primary Care Medecine, Departement of primary Care Medecine, Geneva University HospitalsJ. Colin Internal Medicine department, Trois Chêne HospitalD. Akpokavie Internal Medicine department, Trois Chêne HospitalM. Grandin Faculty of Medicine, University of GenevaA. Merkly Faculty of Medicine, University of GenevaA. Cassini Cantonal Doctor Office, Public Health Department, Canton of Vaud; Infection Prevention and Control Unit, Infectious Diseases Service, Lausanne University Hospital and University of LausanneE. Glampedakis Cantonal Infection Prevention and Control Unit, Cantonal Doctor Office, Public Health Department, Canton of VaudT. Brahier Infectious Diseases Service, Lausanne University Hospital and University of LausanneV. Suttels Infectious Diseases Service, Lausanne University Hospital and University of LausanneV. Prendki Internal Medicine department, Trois Chêne Hospital; Division of Infectious Diseases, Geneva University HospitalsN. Boillat-Blanco Infectious Diseases Service, Lausanne University Hospital and University of Lausanne
|
|
P035
|
|
|
P036
|
|
|
P037
|
|
|
P038
|
Antiviral activity, safety, and pharmacokinetics of GS-1720, a novel weekly oral INSTI
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
C. Fichtenbaum University of Cincinnati College of MedicineM. Berhe North Texas Infectious Disease ConsultantsJ. Bordon Washington Health InstituteJ. Lalezari Quest Clinical ResearchG. Oguchi Midland Florida Clinical Researach CenterG. Sinclair PrismHealth North TexasF. Wang Gilead Sciences, Inc.B. Falkard Gilead Sciences, Inc.H. Zhang Gilead Sciences, Inc.E. Mortensen Gilead Sciences, Inc.T. Grabinger
Speaker
Gilead Sciences Switzerland SàrlJ. Baeten Gilead Sciences, Inc.M. Ramgopal Midway Immunology and Research Center
|
|
P039
|
Bacteriophage therapy plus fecal microbiota transplantation to treat recurrent urinary tract infection (rUTI): a case series
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
S. McCallin
Speaker
Balgrist University HospitalA. Classen University Hospital CologneJ. Scheidegger Balgrist University HospitalS. Dugas Balgrist University HospitalS. Lieberknecht Goethe University Frankfurt, University Hospital FrankfurtH. Koliwer-Brandl University of ZurichS. Lassen Balgrist University HospitalM. Dunne ETH ZurichO. Chemych Balgrist University HospitalP. Nankya Balgrist University HospitalS. Milek Balgrist University HospitalO. Gross Balgrist University HospitalT. Kessler Balgrist University HospitalL. Leitner Balgrist University HospitalM. Vehreschild Goethe University Frankfurt, University Hospital FrankfurtL. Biehl University Hospital Cologne
|
|
P040
|
|
|
P041
|
Impact of antiviral treatment in patients hospitalized with influenza: a retrospective multicentre study in Switzerland over 5 consecutive influenza seasons (2018-2022)
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
K. Hosszu-Fellous Geneva Center for Emerging Viral Diseases, Geneva University Hospitals (HUG), Geneva, SwitzerlandA. Poncet Clinical Research Centre, Faculty of Medicine, University of Geneva, Geneva, SwitzerlandL. Urbini Institute of Global Health, University of Geneva, Geneva, SwitzerlandM. Zanella Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, SwitzerlandD. Flury Division of Infectious Diseases, Infection Prevention and Travel Medicine, Cantonal hospital of St.Gallen, SwitzerlandS. Tschudin Sutter Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, SwitzerlandP. Schreiber Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, SwitzerlandC. Voide Department of Infectious Diseases, Central Institute, Valais Hospital, Sion, SwitzerlandS. Emonet Department of Infectious Diseases, Central Institute, Valais Hospital, Sion, SwitzerlandU. Heininger University Children’s Hospital Basel, SwitzerlandR. Sommerstein Faculty of Healthcare Sciences and Medicine, University of Lucerne, Switzerland and Department Infectious Diseases, Bern University Hospital, SwitzerlandN. Troillet Department of Infectious Diseases, Central Institute, Valais Hospital, Sion, SwitzerlandM. Buettcher Children’s Hospital of Central Switzerland, LUKS, Lucerne, SwitzerlandP. Zimmermann Department of Pediatrics, Fribourg Hospital and Faculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandA. Cusini Division of Infectious Diseases and Infection Control, Cantonal Hospital of Grisons, Chur, SwitzerlandP. Jent Department of Infectious Diseases, Bern University Hospital and University of Bern, Bern, SwitzerlandL. Kaiser Geneva Center for Emerging Viral Diseases, Geneva University Hospitals (HUG), Geneva, SwitzerlandO. Keiser Institute of Global Health, University of Geneva, Geneva, SwitzerlandP. Vetter
Speaker
Geneva Center for Emerging Viral Diseases, Geneva University Hospitals (HUG), Geneva, Switzerland
|
|
P042
|
|
|
P043
|
Measles outbreak in a context of elimination and breakthrough cases: adapting the response to ensure monitoring of symptoms and testing of previously immunised people
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
L. Cobuccio
Speaker
Cantonal Doctor Office, Public Health Department, Canton of Vaud; Infectious Diseases Service, Lausanne University HospitalA. Cassini Cantonal Doctor Office, Public Health Department, Canton of Vaud; Infectious Diseases Service, Lausanne University HospitalE. Glampedakis Cantonal Doctor Office, Public Health Department, Canton of VaudP. Cherpillod Geneva Center for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland; National Measles and Rubella Reference Laboratory, Geneva University Hospitals, Geneva, Switzerland; Laboratory of Virology, Laboratory Medicine Division, Geneva P. Crisinel Unit of paediatric infectious diseases and vaccinology, Service of Paediatrics, Women-Mother-Child Department, Lausanne University Hospital, Lausanne, SwitzerlandF. Perez Rodriguez Geneva Center for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland; National Measles and Rubella Reference Laboratory, Geneva University Hospitals, Geneva, Switzerland; Laboratory of Virology, Laboratory Medicine Division, Geneva M. Attinger Cantonal Doctor Office, Public Health Department, Canton of VaudD. Bachelin Cantonal Doctor Office, Public Health Department, Canton of VaudM. Nahimana Tessemo Cantonal Doctor Office, Public Health Department, Canton of VaudM. Maeusezahl Communicable Disease Division, Federal Office of Public Health, Bern, SwitzerlandP. Sendi Communicable Disease Division, Federal Office of Public Health, Bern, SwitzerlandC. Gardiol Communicable Disease Division, Federal Office of Public Health, Bern, SwitzerlandK. Boubaker Cantonal Doctor Office, Public Health Department, Canton of Vaud
|
|
P044
|
Post-pandemic SARS-CoV-2 vaccination and infection status and risk of influenza-like illnesses and work absenteeism in healthcare workers – a prospective cohort study
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
T. Dörr
Speaker
Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital EpidemiologyJ. Lacy Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland T. Ballouz Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland A. Cusini Cantonal Hospital Graubuenden, Chur, SwitzerlandF. Grässli Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital EpidemiologyS. Haile Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland E. Kocan Geriatric Clinic St. GallenJ. Möller Center for Neurological Rehabilitation ZihlschlachtM. Puhan Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland M. Schlegel Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital EpidemiologyM. von Kietzell Hirslanden Clinic StephanshornM. Rütti Fuerstenland Toggenburg Hospital Group, Wil, SwitzerlandR. Stocker Hirslanden Clinic ZurichD. Vuichard-Gysin Thurgau Hospital Group, Division of Infectious Diseases and Hospital EpidemiologyC. Kahlert Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital EpidemiologyS. Kuster Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital EpidemiologyP. Kohler Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital Epidemiology
|
|
P045
|
Predictors of antibiotic combination therapy in community-acquired pneumonia: A retrospective cohort study
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
A. Dürr University of ZurichF. Baty Cantonal Hospital St.GallenF. Waldeck University Hospital Schleswig-HolsteinF. Rassouli Cantonal Hospital St.GallenS. Kuster Cantonal Hospital St.GallenG. Rohde Goethe University HospitalJ. Rupp University Hospital Schleswig-HolsteinM. Witzenrath Charité-Universitätsmedizin BerlinM. Pletz Jena University HospitalW. Albrich
Speaker
Cantonal Hospital St.Gallen
|
|
P046
|
|
|
P047
|
|
|
P048
|
|
|
P049
|
|
|
P050
|
Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Versus Dolutegravir (DTG)-Based 3-Drug Regimens in Adults With HIV Who Have Suboptimal Antiretroviral Adherence
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
D. Wohl
Speaker
Division of Infectious Diseases, University of North CarolinaK. Andreatta Gilead Sciences, Inc.P. Sax Brigham and Women’s Hospital, Harvard Medical SchoolM. D'Antoni Gilead Sciences, Inc.H. Huang Gilead Sciences, Inc.J. Hindman Gilead Sciences, Inc.T. Grabinger
Speaker
Gilead Sciences Switzerland SàrlC. Callebaut Gilead Sciences, Inc.H. Martin Gilead Sciences, Inc.
|
|
P051
|
|
|
P052
|
|
|
P053
|
|
|
P054
|
|
|
P055
|
Impact of discontinuation of contact precautions on nosocomial cases of ESBL-producing Escherichia coli in a large tertiary care hospital in Switzerland
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
S. Musumeci
Speaker
Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, GenevaR. Grant Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, GenevaJ. Sobel Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, GenevaN. Buetti Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, GenevaS. Harbarth Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva
|
|
P056
|
A Rare Complication of Anti-CD20-Therapy: A Case Report
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
B. Latifi
Speaker
Cantonal Hospital OltenM. Ruf Swiss Tropcial and Public Health Institute / University of BaselM. Concu Swiss Tropcial and Public Health Institute / University of BaselM. Schlageter Institute of Pathology Viollier AG, Allschwil, SwitzerlandR. Piso Cantonal Hospital OltenB. Gottstein Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandM. Hoffmann Cantonal Hospital Olten
|
|
P057
|
HIV-1 RNA Blips and Low-Level Viral Replication: SOLAR (CAB+RPV LA vs. BIC/FTC/TAF)
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
C. Latham ViiV Healthcare, Durham, NC, USAR. Urbaityte GSK, Brentford, UKK. Sutton ViiV Healthcare, Durham, NC, USAW. Spreen ViiV Healthcare, Durham, NC, USAR. D’Amico ViiV Healthcare, Durham, NC, USAP. Rhein
Speaker
ViiV Healthcare GmbH, Münchenbuchsee, Switzerland
|
|
P058
|
3-Year Outcomes for Dolutegravir (DTG) + Lamivudine (3TC) in ART-Naive and Pre-treated People Living With HIV-1 in Germany: Real-world Data From the German URBAN Cohort
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
S. Noe MVZ München am Goetheplatz, Munich, GermanyS. Scholten Praxis Hohenstaufenring, Cologne, GermanyC. Wyen Praxis Ebertplatz, Cologne, GermanyM. Sabranski ICH Study Center, Hamburg, GermanyN. Postel prinzmed, Munich, GermanyO. Degen Universitätsklinikum Hamburg-Eppendorf, Hamburg, GermanyD. Beer Praxis Dr. H. Knechten, Aachen, GermanyK. Ummard-Berger UBN/Praxis, Berlin, GermanyB. Westermayer GSK, Munich, GermanyK. Dymek ViiV Healthcare, Munich, GermanyJ. Scherzer ViiV Healthcare, Munich, GermanyG. Kamber
Speaker
ViiV Healthcare GmbH, Münchenbuchsee, Switzerland
|
|
P059
|
Multidose Oritavancin in clinical practice
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
R. Piso
Speaker
Kantonsspital OltenM. Hoffmann Kant. Spital OltenL. Balmer Kant. Spital OltenC. Fricker BIOLabor OltenP. Thoueille Lausanne University Hospital (CHUV)
|
|
P061
|
|
|
P062
|
|
|
P063
|
|
|
P064
|
|
|
P066
|
Macozinone Revealed: Nanomotion-Based Rapid Phenotypic Evaluation of New Drug Candidate for Mycobacterium tuberculosis Treatment.
Poster (SSI, SSM, SSHH)
SSI – Swiss Society for Infectious Diseases
A. Vocat
Speaker
Resistell AGA. Luraschi-Eggemann Resistell AGC. Antoni Innovative Medicines for Tuberculosis (iM4TB)V. Makarov Innovative Medicines for Tuberculosis (iM4TB)G. Cathomen Resistell AGM. Świątkowski Resistell AGG. Wielgoszewski Resistell AGD. Cichocka Resistell AGG. Greub Lausanne University Hospital and University of LausanneO. Opota Lausanne University Hospital and University of LausanneS. Cole Innovative Medicines for Tuberculosis (iM4TB)A. Sturm Resistell AG
|
|
P067
|
|
|
P068
|
|
|
P069
|
|
|
P070
|
|
|
P071
|
|
|
P072
|
A novel mechanism for archeological iron stabilization using dead biomass of the yeast Meyerozyma spp.
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
P. Petrasz
Speaker
Laboratory of Microbiology, Institute of Biology, University of Neuchâtel, Haute Ecole Arc Conservation Restauration, University of Applied Sciences and Arts HES-SOS. Bindschedler Laboratory of Microbiology, Institute of Biology, University of NeuchâtelL. ThomasArrigo Laboratory of Environmental Chemistry, Institute of Chemistry, University of NeuchâtelP. Junier Laboratory of Microbiology, Institute of Biology, University of NeuchâtelE. Joseph Haute Ecole Arc Conservation Restauration, University of Applied Sciences and Arts HES-SO
|
|
P073
|
|
|
P074
|
Relative inhibitory activities of the broad-spectrum ß-lactamase inhibitor xeruborbactam in comparison with taniborbactam against metallo-ß-lactamases produced in Escherichia coli and Pseudomonas aeruginosa
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
C. Le Terrier
Speaker
Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Division of Intensive care unit, University hospitals of Geneva, Geneva, SwitzerlandS. Freire Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, FribourgC. Viguier Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Infectious Disease Department, University hospital of Toulouse, Toulouse, FranceJ. Findlay Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandP. Nordmann Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, SwitzerlandL. Poirel Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland
|
|
P075
|
Chlamydia vaughanii: the biology and pathogenic role of a newly discovered intracellular bacteria
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
B. Elkamouny
Speaker
Institut de microbiologie de l'Université de LausanneC. Kebbi Beghdadi Institut de microbiologie de l'Université de LausanneB. Marquis Institut de microbiologie de l'Université de LausanneS. Aeby Institut de microbiologie de l'Université de LausanneG. Greub Institut de microbiologie de l'Université de Lausanne
|
|
P076
|
Characterization of Waddlia chondrophila T3SS effectors
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
C. Kebbi Beghdadi
Speaker
Institute of Microbiology (IMU), University Hospital Center and University of Lausanne, Rue du Bugnon 48, CH-1011, Lausanne, SwitzerlandD. Gaillard Institute of Microbiology (IMU), University Hospital Center and University of Lausanne, Rue du Bugnon 48, CH-1011, Lausanne, SwitzerlandG. Greub Institute of Microbiology (IMU), University Hospital Center and University of Lausanne, Rue du Bugnon 48, CH-1011, Lausanne, Switzerland
|
|
P077
|
|
|
P078
|
|
|
P079
|
|
|
P080
|
Lithium bioextraction from geothermal brines
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
G. Laurent
Speaker
Université de NeuchâtelP. Junier Université de NeuchâtelS. Bindschedler Université de Neuchâtel
|
|
P081
|
Survey of carbapenemase-producing Enterobacteriaceae in a private laboratory in Switzerland
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
G. Jost
Speaker
Dianalabs, Geneva, SwitzerlandS. Fauteux-Daniel Dianalabs, Geneva, SwitzerlandM. Rosselin Dianalabs, Geneva, SwitzerlandJ. Kessler-Lambiel National Reference Center for Emerging Antibiotic Resistance (NARA) and Molecular and Medical Microbiology, University FribourgL. Poirel National Reference Center for Emerging Antibiotic Resistance (NARA) and Molecular and Medical Microbiology, University FribourgP. Nordmann National Reference Center for Emerging Antibiotic Resistance (NARA) and Molecular and Medical Microbiology, University FribourgN. Liassine Dianalabs, Geneva, Switzerland
|
|
P082
|
|
|
P083
|
Characterization of the Host Cell Entry Mechanism of Marburg Virus
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
J. Scelle
Speaker
Institute of Microbiology (IMU), University Hospital Center and University of Lausanne, Rue du Bugnon 48, CH-1011, Lausanne, SwitzerlandH. De Jesus Institute of Microbiology (IMU), University Hospital Center and University of Lausanne, Rue du Bugnon 48, CH-1011, Lausanne, SwitzerlandM. Arlettaz Institute of Microbiology (IMU), University Hospital Center and University of Lausanne, Rue du Bugnon 48, CH-1011, Lausanne, SwitzerlandS. Rothenberger Aubert Institute of Microbiology (IMU), University Hospital Center and University of Lausanne, Rue du Bugnon 48, CH-1011, Lausanne, Switzerland
|
|
P084
|
Rapid IPR Pseudomonas NP test for rapid detection of imipenem/relebactam susceptibility/resistance in Pseudomonas aeruginosa
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
M. BOUVIER
Speaker
Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandM. Bachtrazi Hopital Universitaire Alger, AlgeriaL. Poirel Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandP. Nordmann Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
|
|
P085
|
|
|
P086
|
|
|
P087
|
In-vitro activity of dimercapto-succinicid acid in combination with carbapenems against carbapenem-resistant clinical isolates strains and isogenic strains carbapenemases producing Pseudomonas aeruginosa
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
M. BOUVIER
Speaker
Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandS. Freire Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandJ. Findlay Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandP. Nordmann Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
|
|
P088
|
MultiRapid ATB NP test for detecting concomitantly susceptibility and resistance to last-resort novel antibiotics available to treat multidrug-resistant Enterobacterales infections
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
O. Raro
Speaker
University of Fribourg, Fribourg, SwitzerlandM. Bouvier University of Fribourg, Fribourg, SwitzerlandA. Kerbol University of Fribourg, Fribourg, SwitzerlandL. Poirel University of Fribourg, Fribourg, SwitzerlandP. Nordmann University of Fribourg, Fribourg, Switzerland
|
|
P089
|
Immune responses elicited by Janus-faced Mycoplasma mycoides - glycans make the difference.
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
T. Yimthin
Speaker
Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of BernT. Démoulins Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of BernS. Torres-Puig Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of BernL. Eggerschwiler Research Contreacts Animals Group, AgroscopeR. Siegenthaler Research Contreacts Animals Group, AgroscopeN. Ruggli Institute of Virology and Immunology, Bern and MittelhäusernJ. Jores Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern
|
|
P090
|
|
|
P091
|
|
|
P092
|
|
|
P093
|
|
|
P094
|
Intestinal colonization with multidrug-resistant Enterobacterales (MDR-Ent) in expatriates returning to Switzerland
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
E. Campos-Madueno
Speaker
Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandC. Aldeia Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandP. Sendi Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandA. Endimiani Institute for Infectious Diseases, University of Bern, Bern, Switzerland
|
|
P095
|
|
|
P096
|
|
|
P097
|
|
|
P098
|
Comparison of MALDI-TOF identification methods for Mycobacterium other than tuberculosis (MOTT)
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
M. Aruanno
Speaker
Institute of Microbiology (IMU), Centre Hospitalier Universitaire Vaudois (CHUV)G. Gonzalez Institute of Microbiology (IMU), Centre Hospitalier Universitaire Vaudois (CHUV)M. Corthésy Institute of Microbiology (IMU), Centre Hospitalier Universitaire Vaudois (CHUV)D. Jacot Institute of Microbiology (IMU), Centre Hospitalier Universitaire Vaudois (CHUV)O. Opota Institute of Microbiology (IMU), Centre Hospitalier Universitaire Vaudois (CHUV)
|
|
P099
|
Epidemiological changes in Chlamydia pneumoniae molecular detections before, during and after the SARS-CoV-2 pandemics: results of a global survey
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
F. Tagini
Speaker
Lausanne University HospitalS. Anker Uldum Staten Serum InstitutC. Berenga Hospital de la Santa Creu i Sant PauR. Capaul Kantonsspital GraubündenS. Edouard IHU-Méditerranée InfectionA. Fischer Geneva University Hospital (HUG)J. Flipse Rijnstate HospitalD. García Martínez de Artola Hospital Universitario Nuestra Señora de CandelariaD. Goldenberger Basel University HospitalE. Heddema Zuyderland Medical CentreM. Hermans Jeroen Bosch HospitalF. Imkamp University of Zurich, Institute of Medical MicorbiologyD. Kese Institute of Microbiology and Immunology, Faculty of MedicineC. Lejarraga Hospital Universitario CrucesR. Lienhard ADMED MicrobiologieC. Maffioli MCL LaboratoriesV. Matheeussen University Hospital AntwerpP. Meyer-Sauteur University Children's Hospital ZurichI. Mitrovic Luzerner KantonspitalO. Opota Lausanne University HospitalC. Orasch Medisyn SAP. Drevinek Motol University HospitalO. Peuchant Bordeaux University HospitalL. Po-Yu Genomic Center for Infectious DiseasesM. Puolakkainen HUS Diagnostic Center, Microbiology, Virology and ImmunologyM. Remy Medisyn SAK. Thai Star-SHLN. Wohlwend Labormedizinisches Zentrum Dr RischG. Greub Lausanne University Hospital
|
|
P100
|
A novel species of the Actinomycetaceae associated with pyothorax in cats
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
S. Feyer Institute of Veterinary Bacteriology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3001 Bern, SwitzerlandS. Fuss Institute of Veterinary Bacteriology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3001 Bern, SwitzerlandS. Zumwald Institute of Veterinary Bacteriology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3001 Bern, SwitzerlandI. Brodard Institute of Veterinary Bacteriology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3001 Bern, SwitzerlandS. Kittl
Speaker
Institute of Veterinary Bacteriology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland
|
|
P101
|
|
|
P102
|
Characterization of clinical Mycobacterium kansasii complex isolates – epidemiology and resistance profile
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
J. Caro Institute of Medical Microbiology, University of Zurich, Zurich, SwitzerlandF. Kälin National Reference Center for Mycobacteria, Institute of Medical Microbiology, University of Zurich, Zurich, SwitzerlandT. Roloff Institute of Medical Microbiology, University of Zurich, Zurich, SwitzerlandP. Sander National Reference Center for Mycobacteria, Institute of Medical Microbiology, University of Zurich, Zurich, SwitzerlandB. Schulthess
Speaker
National Reference Center for Mycobacteria, Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland
|
|
P103
|
|
|
P104
|
|
|
P105
|
|
|
P106
|
|
|
P107
|
|
|
P108
|
In-vitro activity of the novel ß-lactam/ ß-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 2022
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
M. BOUVIER University of Fribourg, Fribourg, SwitzerlandC. Le Terrier University of Fribourg, Fribourg, SwitzerlandA. Kerbol University of Fribourg, Fribourg, SwitzerlandC. Dell'Acqua University of Fribourg, Fribourg, SwitzerlandP. Nordmann University of Fribourg, Fribourg, SwitzerlandL. Poirel
Speaker
University of Fribourg, Fribourg, Switzerland
|
|
P109
|
|
|
P110
|
Relative inhibitory activities of newly-developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone ß-lactamase inhibitors, against broad-spectrum ampC ß-lactamases
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
C. Le Terrier
Speaker
Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Division of Intensive care unit, University hospitals of Geneva, Geneva, SwitzerlandP. Mlynárčik Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, SwitzerlandM. Sadek Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Department of Food Hygiene and Control, Faculty of Veterinary Medicine, South Valley University, Qena, EgyptP. Nordmann Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, SwitzerlandL. Poirel Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland
|
|
P111
|
Impact of extended-spectrum chromosomal AmpC (ESAC) of Escherichia coli on susceptibility to cefiderocol
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
O. Raro
Speaker
University of Fribourg, Fribourg, SwitzerlandC. Le Terrier University of Fribourg, Fribourg, SwitzerlandP. Nordmann University of Fribourg, Fribourg, SwitzerlandL. Poirel University of Fribourg, Fribourg, Switzerland
|
|
P112
|
Pitfalls and challenges in molecular diagnostics of Corynebacterium diphtheriae - toxin or no toxin?
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
F. Imkamp
Speaker
Institute of Medical Microbiology, University of Zurich, SwitzerlandV. Hinic Institute of Medical Microbiology, University of Zurich, SwitzerlandT. Roloff Institute of Medical Microbiology, University of Zurich, SwitzerlandH. Seth-Smith Institute of Medical Microbiology, University of Zurich, SwitzerlandP. Schreiber Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, SwitzerlandW. Zingg Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, SwitzerlandA. Egli Institute of Medical Microbiology, University of Zurich, Switzerland
|
|
P113
|
|
|
P114
|
|
|
P115
|
|
|
P116
|
|
|
P117
|
|
|
P118
|
Implementation of AI-assisted digital microscopy in a routine hospital mycobacteria laboratory
Poster (SSI, SSM, SSHH)
SSM – Swiss Society for Microbiology
C. Lang
Speaker
Clinical Bacteriology/Mycology, University Hospital Basel, Basel, SwitzerlandM. Schneider Clinical Bacteriology/Mycology, University Hospital Basel, Basel, SwitzerlandS. Turan Clinical Bacteriology/Mycology, University Hospital Basel, Basel, SwitzerlandS. Palladin Clinical Bacteriology/Mycology, University Hospital Basel, Basel, SwitzerlandH. Mannsperger MetaSystems Hard & Software GmbHP. Keller Clinical Bacteriology/Mycology, University Hospital Basel, Basel, Switzerland
|
|
P119
|
|
|
P120
|
|
|
P121
|
|
|
P122
|
|
|
P122a
|
|
|
P123
|
Investigation of the clonal spread of VRE vanA ST612 with reduced daptomycin susceptibility in Switzerland – preliminary results
Poster flashes
SSHH – Swiss Society for Hospital Hygiene
D. Vuichard-Gysin Swiss National Centre for Infection Prevention (Swissnoso) and Thurgau Hospital GroupA. Büchler
Speaker
Swiss National Centre for Infection Prevention (Swissnoso)D. Blanc National Reference Center for Antimicrobial Resistance (NARA), Lausanne University Hospital and University of LausanneP. Keller University Hospital BaselA. Kronenberg University of BernV. Piezzi Federal Office of Public HealthL. Senn Swiss National Centre for Infection Prevention (Swissnoso), Lausanne University Hospital and University of LausanneP. Nordmann National Reference Center for Antimicrobial Resistance (NARA)S. Harbarth Swiss National Centre for Infection Prevention (Swissnoso), Geneva University Hospitals and Faculty of MedicineS. Tschudin-Sutter Swiss National Centre for Infection Prevention (Swissnoso) and University Hospital Basel
|
|
P124
|
From Isolation to Innovation: Establishing "Standard Precautions+" for Advanced Infection Prevention Techniques
Poster flashes
SSHH – Swiss Society for Hospital Hygiene
J. Männer
Speaker
Division of Infectious Diseases, Infection Prevention and Travel Medicine, Cantonal hospital of St.Gallen, SwitzerlandK. Herzog Division of Infectious Diseases and Infection Prevention, Thurgau Hospital Group, Frauenfeld and Muensterlingen, SwitzerlandD. Vuichard-Gysin Division of Infectious Diseases and Infection Prevention, Thurgau Hospital Group, Frauenfeld and Muensterlingen, SwitzerlandJ. Krähemann Division of Infectious Diseases and Infection Prevention, Thurgau Hospital Group, Frauenfeld and Muensterlingen, SwitzerlandS. Kuster Division of Infectious Diseases, Infection Prevention and Travel Medicine, Cantonal hospital of St.Gallen, SwitzerlandD. Flury Division of Infectious Diseases, Infection Prevention and Travel Medicine, Cantonal hospital of St.Gallen, SwitzerlandM. Schlegel Division of Infectious Diseases, Infection Prevention and Travel Medicine, Cantonal hospital of St.Gallen, Switzerland
|
|
P125
|
|
|
P126
|
|
|
P127
|
|
|
P128
|
Administration of Cephalosporine Surgical Antimicrobial Prophylaxis in Low-risk Cholecystectomy and Its Association with Surgical Site Infections
Poster flashes
SSHH – Swiss Society for Hospital Hygiene
L. Florinett
Speaker
Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, SwitzerlandA. Widmer Department of Infectious Diseases, University Hospital Basel, Basel, SwitzerlandN. Troillet Service of Infectious Diseases, Central Institute, Hôpital Du Valais, Sion, SwitzerlandG. Beldi Department for Visceral Surgery and Medicine, Bern University Hospital, Bern, SwitzerlandM. Von Flüe Department of Visceral Surgery, Hirslanden Clinic St. Anna, Lucerne, SwitzerlandS. Harbarth Infection Control Program, Geneva University Hospitals and faculty of medicine, WHO Collaborating Center, Geneva, SwitzerlandR. Sommerstein Faculty of Health Sciences and Medicine, Clinic St. Anna, University of Lucerne, Lucerne, Switzerland
|
|
P129
|
|
|
P130
|
Defining Criteria for the Discontinuation of Isolation in Patients with Carbapenemase-Producing Enterobacteriaceae – A Real-World Experience
Poster flashes
SSHH – Swiss Society for Hospital Hygiene
J. Männer
Speaker
Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandR. Tamò Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandD. Flury Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandM. Schlegel Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandP. Kohler Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, Switzerland
|
|
P131
|
|
|
P132
|
Identifying patients at high risk for multidrug-resistant organisms after hospitalization abroad
Poster flashes
SSHH – Swiss Society for Hospital Hygiene
T. Bopp
Speaker
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zurich, Zurich, SwitzerlandM. Marchesi Institute of Medical Microbiology, University of Zurich, Zurich, SwitzerlandR. Zihlmann Seminar for Statistics, ETH Zurich, Zurich, Switzerland and Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zurich, Zurich, Switzerland, H. Sax Department of Infectious Diseases, Bern University Hospital and University of Bern, Bern, SwitzerlandA. Wolfensberger Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zurich, Zurich, Switzerland
|
|
P133
|
|
|
P134
|
Update of the guidelines of prevention and treatment of infection in nursing homes: A paradigm of intercantonal collaboration for antimicrobial stewardship in long-term care
Poster (SSI, SSM, SSHH)
SSHH – Swiss Society for Hospital Hygiene
E. Glampedakis
Speaker
Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)S. Lajoso Service de gériatrie et de réadaptation gériatrique, Centre hospitalier universitaire vaudois, LausanneA. Malliou Service de gériatrie et de réadaptation gériatrique, Centre hospitalier universitaire vaudois, LausanneN. Perrottet Service de pharmacie, Centre hospitalier universitaire vaudois, LausanneE. Stamm Service de gériatrie et de réadaptation gériatrique, Centre hospitalier universitaire vaudois, LausanneV. Swinnen Service de gériatrie et de réadaptation gériatrique, Centre hospitalier universitaire vaudois, LausanneK. Major Service de gériatrie et de réadaptation gériatrique, Centre hospitalier universitaire vaudois, LausanneM. Snoussi-Pirotte Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)M. Nahimana Tessemo Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)A. Cassini Public Health Department, Canton of Vaud, Lausanne, Switzerland
|
|
P135
|
Long-term, silent MRSA ST4110 outbreak in outpatient wound care revealed by cgMLST
Poster (SSI, SSM, SSHH)
SSHH – Swiss Society for Hospital Hygiene
J. Krähemann
Speaker
Thurgau Hospital Group Münsterlingen and FrauenfeldH. Seth-Smith Institute of Medical Microbiology (UZH)T. Roloff Institute of Medical Microbiology (UZH)K. Herzog Thurgau Hospital Group Münsterlingen and FrauenfeldM. Schlegel Kantonsspital St. Gallen KSSGA. Egli Institute of Medical Microbiology (UZH)D. Vuichard-Gysin Thurgau Hospital Group Münsterlingen and Frauenfeld
|
|
P136
|
Success rates of methicillin-resistant Staphylococcus aureus (MRSA) decolonization and factors associated with failure over a 16 year-period
Poster (SSI, SSM, SSHH)
SSHH – Swiss Society for Hospital Hygiene
N. Bloch Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandM. Seneghini Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandG. Rettenmund Grob Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandD. Flury Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandS. Kuster Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandM. Schlegel Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandP. Kohler
Speaker
Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, Switzerland
|
|
P137
|
|
|
P138
|
|
|
P139
|
Effect of masking policy on influenza vaccine uptake among personnel of long-term care facilities of Vaud
Poster (SSI, SSM, SSHH)
SSHH – Swiss Society for Hospital Hygiene
E. Glampedakis
Speaker
Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)P. Cuiña Iglesias Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)F. Battistella Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)F. Garcia Sanchez Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)C. Riccio Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)M. Snoussi-Pirotte Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)B. Sobgoui Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)M. Nahimana Tessemo Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)A. Cassini Public Health Department, Canton of Vaud
|
|
P140
|
Survey of excreta management in nursing homes of Vaud: a first step towards the development of targeted actions
Poster (SSI, SSM, SSHH)
SSHH – Swiss Society for Hospital Hygiene
B. Sobgoui
Speaker
Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)M. Snoussi-Pirotte Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)E. Glampedakis Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)F. Battistella Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)C. Riccio Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)P. Cuiña Iglesias Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)A. Cassini Public Health Department, Canton of VaudM. Nahimana Tessemo Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)
|
|
P141
|
|
|
P142
|
|
|
P143
|
|
|
P144
|
|
|
P145
|
Ventilator-associated lower respiratory tract infections in intensive care unit patients at a tertiary care centre after implementation of a multifaceted intervention – a before-after study
Poster (SSI, SSM, SSHH)
SSHH – Swiss Society for Hospital Hygiene
N. Bloch Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandJ. Männer
Speaker
Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandS. Rüfenacht Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandW. Frick Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandR. Wunderlich Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandG. Rettenmund Grob Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandG. Kleger Cantonal Hospital St.Gallen, Division of Intensive Care, St.Gallen, SwitzerlandF. Schneider Cantonal Hospital St.Gallen, Division of Intensive Care, St.Gallen, SwitzerlandF. Weiss Cantonal Hospital St.Gallen, Division of Intensive Care, St.Gallen, SwitzerlandM. Kora Cantonal Hospital St.Gallen, Division of Intensive Care, St.Gallen, SwitzerlandS. Kuster Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandM. Schlegel Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandP. Kohler Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, Switzerland
|
|
P146
|
|
|
P147
|
Characterisation of the plasmid population in hospital associated vancomycin resistant Enterococcus faecium
Poster (SSI, SSM, SSHH)
SSHH – Swiss Society for Hospital Hygiene
A. Sobkowiak Institute of Hygiene & Department of Cardiology I – Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital MuensterV. Schwierzeck
Speaker
Institute of Hygiene, University Hospital MuensterA. Oelgemöller Institute of Hygiene, University Hospital MuensterN. Scherff Institute of Hygiene, University Hospital MuensterF. Schuler Institute of Medical Microbiology, University Hospital MuensterV. van Almsick Institute of Hygiene & Department of Cardiology I – Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital MuensterA. Mellmann Institute of Hygiene, University Hospital Muenster
|
|
P148
|
|
|
P149
|
Bacterial contamination of used healthcare workers clothing
Poster (SSI, SSM, SSHH)
SSHH – Swiss Society for Hospital Hygiene
L. Damonti
Speaker
Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland M. Marti Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland S. Droz IFIK BernJ. Marschall Washington University School of Medicine, St. Louis, Missouri, United StatesP. Jent Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
|
|
P150
|
|
|
P151
|
Outbreaks at a Swiss tertiary care hospital
Poster (SSI, SSM, SSHH)
SSHH – Swiss Society for Hospital Hygiene
N. Bloch Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandJ. Männer
Speaker
Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandP. Kohler Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandD. Flury Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandS. Kuster Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, SwitzerlandM. Schlegel Cantonal Hospital St.Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St.Gallen, Switzerland
|
|
P152
|
Correlation of antimicrobial consumption with Clostridioides difficile incidence across the departments of an academic medical centre
Poster (SSI, SSM, SSHH)
SSHH – Swiss Society for Hospital Hygiene
N. Wassilew Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandA. Zehnder Institute for Infectious Diseases, University of BernA. Atkinson Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandA. Kronenberg Institute for Infectious Diseases, University of BernJ. Marschall
Speaker
Division of Infectious Diseases, Washington University School of Medicine
|
|
P153
|
|
|
P154
|
|
|
P155
|
Healthcare workers’ attitudes towards antimicrobial-coated hospital textiles
Poster (SSI, SSM, SSHH)
SSHH – Swiss Society for Hospital Hygiene
M. Faes Hesse
Speaker
University Hospital Zurich, University of ZurichP. Schreiber University Hospital Zurich / University of ZurichA. Sonpar University Hospital Zurich, University of ZurichA. Wolfensberger University Hospital Zurich, University of Zurich
|
